Disposition of 5849 shares by Daniel Bensen of Tyra Biosciences at 20.128 subject to Rule 16b-3

TYRA Stock  USD 15.63  1.20  8.32%   
About 55% of Tyra Biosciences' investors are presently thinking to get in. The analysis of overall sentiment of trading Tyra Biosciences stock suggests that some investors are interested at this time. The current market sentiment, together with Tyra Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Tyra Biosciences stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Tyra Biosciences Officer: Chief Operating Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at macroaxis.com
Disposition of 5849 common stock at 20.128 of Tyra Biosciences by Daniel Bensen on 28th of February 2024. This event was filed by Tyra Biosciences with SEC on 2024-02-28. Statement of changes in beneficial ownership - SEC Form 4

Tyra Biosciences Fundamental Analysis

We analyze Tyra Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tyra Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tyra Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Outstanding

Shares Outstanding Comparative Analysis

Tyra Biosciences is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Tyra Biosciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tyra Biosciences stock to make a market-neutral strategy. Peer analysis of Tyra Biosciences could also be used in its relative valuation, which is a method of valuing Tyra Biosciences by comparing valuation metrics with similar companies.

Peers

Tyra Biosciences Related Equities

DSGNDesign Therapeutics   7.94   
0%
100.0%
HOWLWerewolf Therapeutics   7.69   
0%
96.0%
CCCCC4 Therapeutics   7.10   
0%
89.0%
IPSCCentury Therapeutics   6.73   
0%
84.0%
MLYSMineralys Therapeutics,   4.08   
0%
51.0%
XLOXilio Development   2.80   
0%
35.0%
EWTXEdgewise Therapeutics   2.55   
0%
32.0%
MOLNMolecular Partners   2.53   
0%
31.0%
RAPTRAPT Therapeutics   2.45   
0%
30.0%
IKNAIkena Oncology   2.42   
0%
30.0%
CGEMCullinan Oncology   2.34   
0%
29.0%
STOKStoke Therapeutics   1.95   
0%
24.0%
ERASErasca   1.48   
0%
18.0%
PMVPPmv Pharmaceuticals   1.31   
0%
16.0%
GLUEMonte Rosa   0.84   
0%
10.0%
PHVSPharvaris   0.05   
1.0%
0%
CNTBConnect Biopharma   2.48   
31.0%
0%

Complementary Tools for Tyra Stock analysis

When running Tyra Biosciences' price analysis, check to measure Tyra Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tyra Biosciences is operating at the current time. Most of Tyra Biosciences' value examination focuses on studying past and present price action to predict the probability of Tyra Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tyra Biosciences' price. Additionally, you may evaluate how the addition of Tyra Biosciences to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
CEOs Directory
Screen CEOs from public companies around the world
Stocks Directory
Find actively traded stocks across global markets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules